These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7739575)

  • 41. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120.
    Hoorelbeke B; van Montfort T; Xue J; LiWang PJ; Tanaka H; Igarashi Y; Van Damme EJ; Sanders RW; Balzarini J
    FEBS Lett; 2013 Apr; 587(7):860-6. PubMed ID: 23454641
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concordant modulation of neutralization resistance and high infectivity of the primary human immunodeficiency virus type 1 MN strain and definition of a potential gp41 binding site in gp120.
    Leavitt M; Park EJ; Sidorov IA; Dimitrov DS; Quinnan GV
    J Virol; 2003 Jan; 77(1):560-70. PubMed ID: 12477860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conformation of trimeric envelope glycoproteins: the CD4-dependent membrane fusion mechanism of HIV-1.
    Yingliang W; Hong Y; Zhijian C; Wenxin L
    J Biomol Struct Dyn; 2007 Aug; 25(1):1-9. PubMed ID: 17676933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
    Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
    FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
    Mitchell WM; Ding L; Gabriel J
    AIDS; 1998 Jan; 12(2):147-56. PubMed ID: 9468363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural and immunochemical correspondence between HIV-1 and apolipoprotein A-1 envelope proteins.
    Panin LE; Kostina NE; Poteryaeva ON; Lukashev VA
    Dokl Biochem Biophys; 2001; 377():85-7. PubMed ID: 11712158
    [No Abstract]   [Full Text] [Related]  

  • 49. The disulfide loop of gp41 is critical to the furin recognition site of HIV gp160.
    Sen J; Jacobs A; Jiang H; Rong L; Caffrey M
    Protein Sci; 2007 Jun; 16(6):1236-41. PubMed ID: 17525470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41.
    Huang L; Zhang L; Chen CH
    Curr Pharm Des; 2003; 9(18):1453-62. PubMed ID: 12769725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of HIV-1 gp120 glycoprotein binding to glycolipids.
    McAlarney T; Apostolski S; Lederman S; Latov N
    J Neurosci Res; 1994 Mar; 37(4):453-60. PubMed ID: 8021969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
    Rodriguez D; Rodriguez JR; Esteban M
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of HIV-1 envelope V3 loop cleavage in cell tropism.
    Gu R; Westervelt P; Ratner L
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor.
    Derdeyn CA; Decker JM; Sfakianos JN; Zhang Z; O'Brien WA; Ratner L; Shaw GM; Hunter E
    J Virol; 2001 Sep; 75(18):8605-14. PubMed ID: 11507206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
    Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C
    J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop region.
    Labrosse B; Treboute C; Alizon M
    J Virol; 2000 Mar; 74(5):2142-50. PubMed ID: 10666243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
    Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
    J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop.
    Caffrey M
    Biochim Biophys Acta; 2001 May; 1536(2-3):116-22. PubMed ID: 11406346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
    Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
    Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies.
    Pandey D; Podder A; Pandit M; Latha N
    J Biomol Struct Dyn; 2017 Sep; 35(12):2631-2644. PubMed ID: 27545652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.